Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Obstructive Lung Diseases

Free Subscription Articles published in Allergy Retrieve available abstracts of 89 articles: HTML format

Single Articles

May 2025
1. GATES J, Haris F, Cefaloni F, Khooshemehri P, et al
   Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma.
   Allergy. 2025 May 14. doi: 10.1111/all.16590.
   PubMed     Abstract available
   
   
   
2. LESKIEN M, Thiering E, Yu Z, Huels A, et al
   Childhood Asthma and Allergy Are Related to Accelerated Epigenetic Aging.
   Allergy. 2025 May 10. doi: 10.1111/all.16583.
   PubMed     Abstract available
   
   
   
3. PRICE OJ, Papadopoulos NG, Amerigo DA, Backer V, et al
   Exercise Recommendations and Practical Considerations for Asthma Management-An EAACI Position Paper.
   Allergy. 2025 May 6. doi: 10.1111/all.16573.
   PubMed     Abstract available
   
   
   
4. TOURLAKOPOULOS K, Mavrovounis G, Kontopoulou L, Polyzois S, et al
   Unmasking Convergent Inflammatory and Oxidative Pathways in Asthma.
   Allergy. 2025 May 6. doi: 10.1111/all.16575.
   PubMed    
   
   
   April 2025
5. AN J, Park J, Do AR, Seo S, et al
   Differential DNA Methylation in Peripheral Blood Mononuclear Cells Reflects Asthma Control Status in Adults.
   Allergy. 2025 Apr 19. doi: 10.1111/all.16566.
   PubMed    
   
   
   
6. CHOI S, Yoo SA, Ji KY, Jung DH, et al
   Asthma Alleviation by Ginsenoside Rb1 via Promotion of Treg Proliferation and Inflammatory T Cell Inhibition.
   Allergy. 2025 Apr 19. doi: 10.1111/all.16551.
   PubMed     Abstract available
   
   
   
7. FRICKER M, Harrington J, Hiles SA, Gibson PG, et al
   Circulating Mast Cell Progenitors Are Depleted by Benralizumab in Severe Asthma.
   Allergy. 2025 Apr 19. doi: 10.1111/all.16553.
   PubMed    
   
   
   
8. KLAIN A, Indolfi C, Grella C, Colosimo S, et al
   Correspondence to "Omalizumab Reduces Anaphylactic Reactions and Allows Food Introduction in Food-Allergic in Children With Severe Asthma: An Observational Study".
   Allergy. 2025 Apr 17. doi: 10.1111/all.16560.
   PubMed    
   
   
   
9. AGACHE I, Adcock IM, Akdis CA, Akdis M, et al
   Reply to Correspondence: The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.
   Allergy. 2025 Apr 11. doi: 10.1111/all.16557.
   PubMed    
   
   
   
10. 
    Correction to: D.J. Jackson, M.E. Wechsler, G. Brusselle, R. Buhl. Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents. Allergy 2024;1-10. https://doi.org/10.1111/all.16346.
    Allergy. 2025 Apr 3. doi: 10.1111/all.16541.
    PubMed    
    
    
    
11. HILLSON K, Fontanella S, Almeida H, Pavlou B, et al
    Point-of-Care Blood Eosinophils to Predict Preschool Wheeze Attacks.
    Allergy. 2025;80:1038-1046.
    PubMed     Abstract available
    
    
    
12. MANN-NUTTEL R, Mandal S, Armbruster M, Puttagunta L, et al
    Human Pulmonary Neuroendocrine Cells Respond to House Dust Mite Extract With PAR-1 Dependent Release of CGRP.
    Allergy. 2025;80:976-985.
    PubMed     Abstract available
    
    
    March 2025
13. LIPWORTH BJ, Greig R, Chan R, Kuo CR, et al
    Head-To-Head Comparison of Biologic Efficacy in Asthma: What Have We Learned?
    Allergy. 2025 Mar 29. doi: 10.1111/all.16537.
    PubMed     Abstract available
    
    
    
14. SEMENZATO U, Previtero D, Padrin Y, Baraldo S, et al
    Correspondence to "The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper".
    Allergy. 2025 Mar 11. doi: 10.1111/all.16523.
    PubMed    
    
    
    
15. HUANG K, Liu M, Wang W, Shi H, et al
    Asthma Control and Risk Factors for Poor Asthma Outcomes in Chinese Asthma Patients: Baseline Analysis of a Multi-Centre, Single-Arm Study (CARE4ALL).
    Allergy. 2025 Mar 9. doi: 10.1111/all.16522.
    PubMed    
    
    
    
16. HSIN L, Hew M, Aui PM, Deckert K, et al
    A Single Multiplex CytoBas Assay Incorporating Eight Major Components for Accurate Detection of Allergen Sensitization in Asthma and Allergic Rhinitis.
    Allergy. 2025 Mar 7. doi: 10.1111/all.16513.
    PubMed     Abstract available
    
    
    February 2025
17. AGACHE I, Annesi-Maesano I, Cecchi L, Biagioni B, et al
    EAACI Guidelines on Environmental Science for Allergy and Asthma-Recommendations on the Impact of Indoor Air Pollutants on the Risk of New-Onset Asthma and on Asthma-Related Outcomes.
    Allergy. 2025 Feb 28. doi: 10.1111/all.16502.
    PubMed     Abstract available
    
    
    
18. DOMINGO C, Busse WW, Hanania NA, Ertugrul M, et al
    The Direct and Indirect Role of IgE on Airway Epithelium in Asthma.
    Allergy. 2025 Feb 18. doi: 10.1111/all.16459.
    PubMed     Abstract available
    
    
    
19. KIM MS, Lee HW, Choi MS, Lee HS, et al
    Association Between Prevalence of Anemia and Asthma Severity.
    Allergy. 2025 Feb 18. doi: 10.1111/all.16506.
    PubMed    
    
    
    
20. HSU YT, Wu CC, Wang CC, Sheu CC, et al
    Differential Risks of Exposure to Acrylamide in Adult Asthma Clusters.
    Allergy. 2025 Feb 15. doi: 10.1111/all.16503.
    PubMed    
    
    
    
21. KOTSIOU OS, Kirgou P, Siachpazidou D, Bartziokas K, et al
    Correspondence: "Challenging the Frontier: Bridging Systemic Biomarkers and Small Airway Dynamics in Severe Asthma Management".
    Allergy. 2025 Feb 10. doi: 10.1111/all.16498.
    PubMed    
    
    
    
22. MARTIN-GONZALEZ E, Perez-Garcia J, Herrera-Luis E, Martin-Almeida M, et al
    Epigenome-Wide Association Study of Asthma Exacerbations in Europeans.
    Allergy. 2025 Feb 5. doi: 10.1111/all.16490.
    PubMed     Abstract available
    
    
    January 2025
23. KIM DY, Lee S, Jung JH, Sub Y, et al
    GWAS Identifies CACNA2D3 Associated With Asthma and Atopic Dermatitis Multimorbidity in Children.
    Allergy. 2025 Jan 27. doi: 10.1111/all.16483.
    PubMed    
    
    
    
24. ZHANG JL, Zhao CY, Xu XH, Shi C, et al
    Association Between Long-Term Exposure to Ambient Air Pollution and the Risk of Recurrent Asthma Hospitalizations.
    Allergy. 2025 Jan 24. doi: 10.1111/all.16476.
    PubMed    
    
    
    
25. CHANG FM, Lin YF, Chuang HC, Hsu JW, et al
    Early Puberty and Risk of Asthma: Meta-Analysis and Systematic Review.
    Allergy. 2025 Jan 11. doi: 10.1111/all.16471.
    PubMed    
    
    
    
26. FRIEDRICH A, Schmitz MT, Gossmann Y, Redler S, et al
    Comorbid Bronchial Asthma, Atopic Dermatitis and Hashimoto's Thyroiditis Are Risk Factors for Early-Onset, Severe and Prolonged Alopecia Areata.
    Allergy. 2025 Jan 8. doi: 10.1111/all.16468.
    PubMed    
    
    
    
27. DAUD T, Roberts S, Zounemat Kermani N, Richardson M, et al
    The Role of WNT5a and TGF-beta1 in Airway Remodelling and Severe Asthma.
    Allergy. 2025 Jan 3. doi: 10.1111/all.16445.
    PubMed     Abstract available
    
    
    December 2024
28. DOYEN V, Migueres N, van Kampen V, Suojalehto H, et al
    Exhaled Nitric Oxide and Sputum Eosinophils Are Complementary Tools for Diagnosing Occupational Asthma.
    Allergy. 2024 Dec 27. doi: 10.1111/all.16447.
    PubMed     Abstract available
    
    
    
29. PACHECO DA SILVA E, Weinmann T, Gerlich J, Weinmayr G, et al
    Exposure Profiles for the Long-Term Use of Disinfectants and Cleaning Products and Asthma.
    Allergy. 2024 Dec 26. doi: 10.1111/all.16456.
    PubMed     Abstract available
    
    
    
30. SLOB EMA, Vijverberg SJH, Ruffles T, Noij LCE, et al
    Genotype-Guided Asthma Treatment Reduces Exacerbations in Children: Meta-Analysis of Two RCTs.
    Allergy. 2024 Dec 26. doi: 10.1111/all.16438.
    PubMed     Abstract available
    
    
    
31. ESNAULT S, Bernau K, Floerke HL, Dendooven A, et al
    Oncostatin-M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe Asthma.
    Allergy. 2024 Dec 21. doi: 10.1111/all.16453.
    PubMed    
    
    
    
32. LUO H, Wen F
    Global Burden of Asthma and Atopic Dermatitis in 2021: A Systemic Analysis of the Global Burden of Disease Study 2021.
    Allergy. 2024 Dec 20. doi: 10.1111/all.16449.
    PubMed    
    
    
    
33. MICHILS A, Hackx M, Mlynarski L, Haccuria A, et al
    How FEV(1) Improvement Induced by Anti-IL-5 in Severe Type-2 Asthma Is Linked to Mucus Plugs Clearance.
    Allergy. 2024 Dec 19. doi: 10.1111/all.16441.
    PubMed    
    
    
    
34. FREEMAN A, Minnion M, Lee PH, Haitchi HM, et al
    Circulating Nitrite in Severe Asthma: Just Another Biomarker or Novel Treatment Target?
    Allergy. 2024 Dec 19. doi: 10.1111/all.16435.
    PubMed    
    
    
    
35. CONTRERAS N, Escolar-Pena A, Delgado-Dolset MI, Fernandez P, et al
    Multiomic Integration Analysis for Monitoring Severe Asthma Treated With Mepolizumab or Omalizumab.
    Allergy. 2024 Dec 18. doi: 10.1111/all.16434.
    PubMed     Abstract available
    
    
    
36. AGACHE I, Adcock IM, Akdis CA, Akdis M, et al
    The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.
    Allergy. 2024 Dec 16. doi: 10.1111/all.16436.
    PubMed     Abstract available
    
    
    
37. LIAO TC, Tsai PC, Lin MC, Wu CC, et al
    Exploring Occupational Asthmagen-Related Asthma Phenotypes: A Cluster Analysis and Machine Learning Study.
    Allergy. 2024 Dec 16. doi: 10.1111/all.16422.
    PubMed    
    
    
    
38. SOENDERGAARD MB, Hansen S, Hakansson KEJ, von Bulow A, et al
    Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe Asthma.
    Allergy. 2024 Dec 14. doi: 10.1111/all.16425.
    PubMed     Abstract available
    
    
    
39. BILO MB, Martini M, Antonicelli L, de Michele F, et al
    Real-World Finetuning of Biomarkers in Severe Asthma: Longitudinal Latent Class Analysis From the Italian Registry on Severe Asthma (IRSA).
    Allergy. 2024 Dec 6. doi: 10.1111/all.16409.
    PubMed    
    
    
    
40. STOKHOLM J, Thorsen J, Schoos AM, Rasmussen MA, et al
    Infantile colic is associated with development of later constipation and atopic disorders.
    Allergy. 2024;79:3360-3372.
    PubMed     Abstract available
    
    
    November 2024
41. VARRICCHI G, Poto R, Lommatzsch M, Brusselle G, et al
    Biologics and airway remodeling in asthma: early, late, and potential preventive effects.
    Allergy. 2024 Nov 9. doi: 10.1111/all.16382.
    PubMed     Abstract available
    
    
    
42. CHOI DY, Kim AS, Park SY, Kim JH, et al
    Gut permeability and its correlation with patient's traits and blood inflammatory markers in severe asthma: Real-world assessment from the Korean severe asthma registry-2 (KoSAR-2).
    Allergy. 2024 Nov 8. doi: 10.1111/all.16392.
    PubMed    
    
    
    
43. DRAGUNAS G, Koster CS, de Souza Xavier Costa N, Melgert BN, et al
    Neuroplasticity and neuroimmune interactions in fatal asthma.
    Allergy. 2024 Nov 1. doi: 10.1111/all.16373.
    PubMed     Abstract available
    
    
    October 2024
44. VITTE J, Bouazzi L, Barbe C, Pham BN, et al
    Pesticides as an overlooked exposomic association in allergic asthma exacerbations: A nationwide database study.
    Allergy. 2024 Oct 29. doi: 10.1111/all.16380.
    PubMed    
    
    
    
45. MESSAOUD-NACER Y, Culerier E, Rose S, Maillet I, et al
    STING-dependent induction of neutrophilic asthma exacerbation in response to house dust mite.
    Allergy. 2024 Oct 28. doi: 10.1111/all.16369.
    PubMed     Abstract available
    
    
    
46. FELESZKO W, Makrinioti H, Nalej M, Ooka T, et al
    Early-life exposure to residential greenness and risk of asthma in a U.S. bronchiolitis cohort.
    Allergy. 2024 Oct 21. doi: 10.1111/all.16359.
    PubMed     Abstract available
    
    
    
47. BEERWEILER CC, Salvermoser M, Theodorou J, Bock A, et al
    Farm-dust mediated protection of childhood asthma: Mass cytometry reveals novel cellular regulation.
    Allergy. 2024 Oct 14. doi: 10.1111/all.16347.
    PubMed     Abstract available
    
    
    
48. JACKSON DJ, Wechsler ME, Brusselle G, Buhl R, et al
    Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents.
    Allergy. 2024 Oct 12. doi: 10.1111/all.16346.
    PubMed     Abstract available
    
    
    September 2024
49. LIN N, Huang Z, Li J, Dong J, et al
    Effects of high-intensity interval training on exercise capacity and asthma-related outcomes in children: A systematic review.
    Allergy. 2024 Sep 30. doi: 10.1111/all.16336.
    PubMed    
    
    
    
50. VAZQUEZ-MERA S, Martelo-Vidal L, Miguens-Suarez P, Bravo SB, et al
    Exploring CD26(-/lo) subpopulations of lymphocytes in asthma phenotype and severity: A novel CD4(+) T cell subset expressing archetypical granulocyte proteins.
    Allergy. 2024 Sep 25. doi: 10.1111/all.16327.
    PubMed     Abstract available
    
    
    
51. MUKHERJEE M, Bernaola J, Nolasco S, Kjarsgaard M, et al
    Up-dosing of reslizumab in severe asthmatics with persistent sputum eosinophilia: A feasibility study.
    Allergy. 2024 Sep 17. doi: 10.1111/all.16322.
    PubMed    
    
    
    
52. ARASI S, Cafarotti A, Galletta F, Panetta V, et al
    Omalizumab reduces anaphylactic reactions and allows food introduction in food-allergic in children with severe asthma: An observational study.
    Allergy. 2024 Sep 16. doi: 10.1111/all.16314.
    PubMed     Abstract available
    
    
    
53. GIJSEN CEW, Bogers TRP, Muris JWM, van van Horck MWP, et al
    Letter to the editor: Efficacy of eHealth monitoring in pediatric asthma.
    Allergy. 2024 Sep 13. doi: 10.1111/all.16317.
    PubMed    
    
    
    
54. RHEE H, Henderson LM, Bauer RN, Wong K, et al
    Airway tryptase levels inform the lack of clinical efficacy of the tryptase inhibitor MTPS9579A in asthma.
    Allergy. 2024 Sep 9. doi: 10.1111/all.16309.
    PubMed     Abstract available
    
    
    
55. MELGAARD ME, Jensen SK, Eliasen A, Pedersen CT, et al
    Asthma development is associated with low mucosal IL-10 during viral infections in early life.
    Allergy. 2024 Sep 2. doi: 10.1111/all.16276.
    PubMed     Abstract available
    
    
    August 2024
56. CHANTRAN Y, Choi S, Roda C, Nicaise-Roland P, et al
    Higher levels of basal serum tryptase are associated with sensitization, FeNO, allergic morbidity, and lower control of allergic asthma in teenagers from the PARIS birth cohort.
    Allergy. 2024 Aug 19. doi: 10.1111/all.16284.
    PubMed    
    
    
    
57. JABEEN MF, Sanderson ND, Tine M, Donachie G, et al
    Species-level, metagenomic and proteomic analysis of microbe-immune interactions in severe asthma.
    Allergy. 2024 Aug 11. doi: 10.1111/all.16269.
    PubMed     Abstract available
    
    
    
58. FRICKER M, Harrington J, Hiles SA, Gibson PG, et al
    Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma.
    Allergy. 2024 Aug 8. doi: 10.1111/all.16267.
    PubMed     Abstract available
    
    
    
59. MARROCCO A, Mitchel JA, Parker M, McGill M, et al
    Transcriptomic profiles of well-differentiated airway epithelial cells in response to environmental triggers of asthma exacerbation.
    Allergy. 2024 Aug 7. doi: 10.1111/all.16226.
    PubMed    
    
    
    
60. RUPANI H, Busse WW, Howarth PH, Bardin PG, et al
    Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma.
    Allergy. 2024 Aug 1. doi: 10.1111/all.16242.
    PubMed     Abstract available
    
    
    July 2024
61. XU Q, Jia J, Lin H, Liang D, et al
    Systemic reactions to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis and/or asthma: A real-life, multi-center study.
    Allergy. 2024 Jul 26. doi: 10.1111/all.16254.
    PubMed    
    
    
    
62. CHIN-SEE-CHONG TCT, Valk JPMJV, Layhadi JAJ, Shamji MHM, et al
    Clinical efficacy of tezepelumab in pre-selected non-type 2 asthma patients.
    Allergy. 2024 Jul 22. doi: 10.1111/all.16237.
    PubMed    
    
    
    
63. FIETEN KB, Drijver-Messelink MT, Wolters R, Hilvering B, et al
    Alpine altitude climate treatment improves asthma control, irrespective of biologics use.
    Allergy. 2024 Jul 12. doi: 10.1111/all.16233.
    PubMed    
    
    
    
64. PERRET JL, Idrose NS, Walters EH, Bui DS, et al
    Childhood infections, asthma and allergy trajectories, and chronic rhinosinusitis in middle age: A prospective cohort study across six decades.
    Allergy. 2024 Jul 10. doi: 10.1111/all.16184.
    PubMed     Abstract available
    
    
    
65. DUMAS O, Le Moual N
    Correspondence to "The impact of indoor pollution on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma".
    Allergy. 2024 Jul 7. doi: 10.1111/all.16224.
    PubMed    
    
    
    June 2024
66. CHEN DF, Su ZQ, Luo YL, Zhou ZQ, et al
    Establishment of a novel severe asthma canine model: Feasible research platform of respiratory intervention therapies.
    Allergy. 2024 Jun 25. doi: 10.1111/all.16207.
    PubMed    
    
    
    
67. DENTON E, Hew M, Peters MJ, Upham JW, et al
    Real-world biologics response and super-response in the International Severe Asthma Registry cohort.
    Allergy. 2024 Jun 22. doi: 10.1111/all.16178.
    PubMed     Abstract available
    
    
    
68. CANELO-AYBAR C, Nieto-Gutierrez W, Rodriguez-Tanta LY, Cantero-Forti Y, et al
    Reply to correspondence: Correspondence to "the impact of indoor pollution on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma".
    Allergy. 2024 Jun 16. doi: 10.1111/all.16195.
    PubMed    
    
    
    
69. BAL C, Stoshikj S, Milger K, Skowasch D, et al
    German asthma net: Nasal polyposis in patients in the severe asthma registry.
    Allergy. 2024 Jun 12. doi: 10.1111/all.16186.
    PubMed    
    
    
    May 2024
70. MUSIOL S, Harris CP, Gschwendtner S, Burrell A, et al
    The impact of high-salt diet on asthma in humans and mice: Effect on specific T-cell signatures and microbiome.
    Allergy. 2024 May 26. doi: 10.1111/all.16148.
    PubMed     Abstract available
    
    
    
71. AGACHE I, Ricci-Cabello I, Canelo-Aybar C, Annesi-Maesano I, et al
    The impact of exposure to tobacco smoke and e-cigarettes on asthma-related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma.
    Allergy. 2024 May 23. doi: 10.1111/all.16151.
    PubMed     Abstract available
    
    
    
72. YANG Y, Cui L, Yu P, Guo J, et al
    Proteomics and metabolomics of sputum reveal the potential impact of allergic rhinitis on asthma.
    Allergy. 2024 May 11. doi: 10.1111/all.16153.
    PubMed    
    
    
    
73. RANJBAR M, Whetstone CE, Cusack RP, Al-Sajee D, et al
    Comparison of upper and lower airway expression of SARS-COV-2 receptors in allergic asthma.
    Allergy. 2024 May 10. doi: 10.1111/all.16157.
    PubMed    
    
    
    
74. PFAAR O, Sousa-Pinto B, Papadopoulos NG, Larenas-Linnemann DE, et al
    Digitally-enabled, person-centred care (PCC) in allergen immunotherapy: An ARIA-EAACI Position Paper.
    Allergy. 2024 May 3. doi: 10.1111/all.16135.
    PubMed     Abstract available
    
    
    
75. ROTH-WALTER F, Adcock IM, Benito-Villalvilla C, Bianchini R, et al
    Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology.
    Allergy. 2024;79:1089-1122.
    PubMed     Abstract available
    
    
    April 2024
76. HALVARD HANSEN ES, Kaiser H, Hansen KT, Bonnelykke K, et al
    Association between Apgar scores within normal range and development of asthma, allergic rhinitis and eczema in childhood: A Danish nationwide register study.
    Allergy. 2024 Apr 27. doi: 10.1111/all.16143.
    PubMed    
    
    
    
77. MICHILS A, Makhoul JP, Blekic N, Haccuria A, et al
    Continuous improvement of FEV(1) in severe eosinophilic asthmatics on anti-interleukin-5 therapy.
    Allergy. 2024 Apr 24. doi: 10.1111/all.16139.
    PubMed    
    
    
    
78. NAIR P, Radford K, Nunomura S, Mukherjee M, et al
    Response of sputum periostin to anti-T2 biologics treatment in severe asthma.
    Allergy. 2024 Apr 23. doi: 10.1111/all.16131.
    PubMed    
    
    
    
79. AGACHE I, Annesi-Maesano I, Cecchi L, Biagioni B, et al
    EAACI guidelines on environmental science for allergy and asthma: The impact of short-term exposure to outdoor air pollutants on asthma-related outcomes and recommendations for mitigation measures.
    Allergy. 2024 Apr 2. doi: 10.1111/all.16103.
    PubMed     Abstract available
    
    
    March 2024
80. 
    Correction to Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics.
    Allergy. 2024 Mar 12. doi: 10.1111/all.16081.
    PubMed    
    
    
    
81. JUTEL M, Klimek L, Richter H, Bruggenjurgen B, et al
    House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control-A RWE study.
    Allergy. 2024 Mar 2. doi: 10.1111/all.16052.
    PubMed     Abstract available
    
    
    
82. OKUNISHI K, Kochi Y, Zhao M, Wang H, et al
    Munc13-4 regulates asthma and obesity in mice by controlling functions of CD11c(+) antigen-presenting cells.
    Allergy. 2024 Mar 1. doi: 10.1111/all.16087.
    PubMed    
    
    
    February 2024
83. CARUSO C, Ciasca G, Baglivo I, Di Santo R, et al
    Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?
    Allergy. 2024 Feb 29. doi: 10.1111/all.16082.
    PubMed     Abstract available
    
    
    
84. NADIF R, Henny J, Tsiavia T, Ribet C, et al
    Blood basophils and asthma among participants from CONSTANCES, the French population-based cohort.
    Allergy. 2024 Feb 29. doi: 10.1111/all.16093.
    PubMed    
    
    
    
85. CHEN X, He YQ
    Correspondence to "intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL-6-mediated protection associated with cecal microbiota changes".
    Allergy. 2024 Feb 25. doi: 10.1111/all.16075.
    PubMed    
    
    
    
86. MORTZ CG, Parke L, Rasmussen HM, Kjaer HF, et al
    A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy.
    Allergy. 2024 Feb 17. doi: 10.1111/all.16046.
    PubMed     Abstract available
    
    
    December 2023
87. HAMELMANN E, Hammerby E, Scharling KS, Pedersen M, et al
    Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children.
    Allergy. 2023 Dec 26. doi: 10.1111/all.15985.
    PubMed     Abstract available
    
    
    
88. SULLIVAN MO, Curtin M, Flynn R, Cronin C, et al
    Telehealth interventions for transition to self-management in adolescents with allergic conditions: A systematic review.
    Allergy. 2023 Dec 1. doi: 10.1111/all.15963.
    PubMed     Abstract available
    
    
    November 2023
89. LINDQVIST M, Leth-Moller KB, Linneberg A, Kull I, et al
    Natural course of pollen-induced allergic rhinitis from childhood to adulthood: A 20-year follow up.
    Allergy. 2023 Nov 2. doi: 10.1111/all.15927.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.